Posts

Showing posts with the label Pharmaceutical

Increasing Prevalence/Incidence of Obesity to Augment the Orlistat Market Growth

Image
  Orlistat, also known as Xenical, is a dietary supplement that has recently gained the Food and Drug Administration (FDA) approval. This herb, which also goes by the names Phentermine and Orlistat, was originally developed to help people who suffer from acid reflux and heartburn, but it's recently been used to help people lose weight. Orlistat helps suppress the appetite and stimulates the release of serotonin. This reduces the desire for food and helps increase the number of calories burned during exercise. It can be purchased over-the-counter and comes in various flavors, such as butterscotch, raspberry, orange, and chocolate. Orlistat is a type of drug designed to treat obesity. The primary function of orlistat is to inhibit the absorption of fat from the diet consumed by humans. Moreover, orlistat helps prevent the onset of type 2 diabetes and reduce blood pressure in obese people. Orlistat does not allow one to regain lost weight and does not block the absorption of fats fr...

The Global Spinal Muscular Atrophy Market Continues To Grow Owing To the Newly Launched FDA Approved Products in the Market and Easier Government Reimbursement Policies across the Globe

Image
  Spinal muscular atrophy, also known as SMA, is a progressive condition wherein nerve fibers in the spinal cord are replaced by scar tissues. This degeneration occurs predominantly in the long muscle fibers and involves the progressive weakening and eventually the complete loss of muscle function. This condition can result from a variety of pathological conditions, including traumatic injuries, strokes, age-related macular degeneration, and spinal cord injuries. It can also be the result of various hormonal changes, such as during puberty and pregnancy or the body's response to disease or injury. Spinal muscular atrophy can have several different potential causes, including genetic factors, exposure to disease and/or injury, abnormalities in the spine, as well as the progressive weakening of muscles at the point of its attachment to the spinal cord. Market Dynamics The factors driving the global growth of the spinal muscular atrophy market include an increase in the cases of ...